NAS:AEZS (USA) Also Trade In: Canada Germany UK

AEterna Zentaris Inc $ 0.71 -0.0613 (-7.97%)

Volume:
11,344,349
Avg Vol (1m):
5,831,418
Market Cap $:
43.61 Mil
Enterprise Value $:
21.23 Mil
P/E (TTM):
0.00
P/B:
2.46
Warning! GuruFocus has detected 4 Severe warning signs with AEZS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

AEZS News and Headlines - AEterna Zentaris Inc

GuruFocus Articles Total 5
  • 1

Schlumberger, Honeywell up while GE, Colgate-Palmolive down on quarterly results

While the dollar fell against most of its peers, the DXY Index is trading 0.17% in the red, the Dow Jones Industrial Average advanced to 21,611.78; the S&P 500 index rose to 2,473.45 and the Nasdaq Composite jumped to 6,390. The yield on 10-year U.S. Treasury Notes is 2.24%.

Several companies reported earnings before the bell this morning. Among them were:

Schlumberger Ltd. (SLB) shares were up in pre-market trading as the company reported better-than-expected earnings for its second quarter. EPS of 35 cents beat expectations by five cents expectations and revenue of $7.46 billion beat estimates by $220 million.

55 Views    Omar Venerio    2017-07-21 16:52
Year 2013 has been called [i]the year of the biotech return[/i]. According to BioTechNow, the sector is doing better than it has since 2007. One of the highlighted companies today, StemCells Inc. (STEM) just completed its successful IPO last week. The GuruFocus Value Screen for finding [url=http://www.gurufocus.com/52weeklow.php?tab=guru&datespan=52w]52-Week Lows[/url] shows the biotechnology sector with 25 companies out of 176 on a 52-week low. The low ratio is 0.14. Here’s a look at three waning biotech companies and the billionaires who hold them. All companies selected are more than 42% off a 52-week high. [b]Highlight: AEterna Zentaris Inc. (AEZS)[/b] The current AEZS
538 Views    Sally Jones    2013-10-16 12:08
[b]Keryx Biopharmaceuticals (KERX)[/b] has a lot of [url=http://www.thestreet.com/story/11479203/1/keryx-perifosine-colon-cancer-trial-fails.html]negative press[/url] shining down darkly upon it after its cancer drug blundered in its final clinical phase. Keryx had a partnership with [b]AEternia Zentaris[/b][b] (AEZS)[/b][b] [/b]to create and take the cancer fighting therapy Perifosine through clinical trials into FDA approval. The drug failed to increase the survival rate of patients compared to the placebo patients in phase 3, causing a warranted 68% fall in share value. It is pretty certain that Perifosine will not pass FDA regulation. There is a possibility of life after drug death for AEZS, but I believe Keryx won't
1124 Views    StockCroc    2012-04-24 22:01
The genius marriage of biology and pharmaceuticals has spawned many amazing offspring. [b]Keryx Biopharmaceuticals (KERX)[/b] is among them. This company is a forerunner in the arena of treatments for cancer and renal diseases. Its activities revolve around acquiring, developing and making commercially available the drugs used in the treatment of the aforementioned conditions. Think Keryx, and the word “perifosine” immediately comes to mind. Lately, there has been a lot of news floating about its work on this orally administered anti-cancer agent. Perifosine or KRX-0401 was expected to be big, though it failed phase 3 trials. If you are interested in
603 Views    InvestmentUnderground    2012-04-12 22:18
In the recently published biography of [url=http://www.gurufocus.com/StockBuy.php?GuruName=Warren+Buffett]Warren Buffett[/url], titled The Snowball, a young and not-yet wealthy [url=http://www.gurufocus.com/StockBuy.php?GuruName=Charlie+Munger]Charlie Munger[/url] asks Buffett how to get rich by investing. Munger and Buffett would later become one of the most famous pairings in all of business but at that time, Buffett advised his new friend, “Coat-tail, Charlie, you’ve got to coat-tail.” This screen is derived from the premise of coat-tailing. After all, if it’s good enough for Buffett, it’s good enough for us. Using the gurufocus' premium screening tools, I selected a handful of the most renowned value investors who file SEC 13F-HR filings.
5121 Views    dvb    2010-01-05 18:39

Headlines Total 59
  • 1

2021-01-15 $ 0.64 (-5.88%)
11:01am
2021-01-05 $ 0.5168 (0.37%)
10:59am
2020-12-07 $ 0.376 (-10.94%)
11:01am
2020-11-16 $ 0.35 (0.2%)
11:01am
2020-11-06 $ 0.3095 (-3.28%)
11:00am
2020-09-16 $ 0.376 (-0.87%)
11:00am
2020-09-09 $ 0.3885 (2.24%)
11:01am
2020-09-08 $ 0.38 (-4.98%)
11:00am
2020-08-06 $ 0.4608 (4.21%)
7:02pm
2020-08-03 $ 0.429 (-8.63%)
11:01am
2020-07-31 $ 0.4695 (-1.61%)
7:00am
2020-07-30 $ 0.4772 (1.02%)
7:00am
2020-07-29 $ 0.4724 (-1.4%)
7:08am
2020-07-08 $ 0.5168 (24.53%)
7:00pm
2020-07-02 $ 0.54 (-32.67%)
11:00pm
2020-06-25 $ 0.908 (5.58%)
11:00am
2020-06-08 $ 1.17 (1.74%)
11:00am
2020-06-05 $ 1.17 (0.86%)
7:00pm
2020-05-16 $ 0.93 (-3.99%)
7:01pm
2020-05-08 $ 1.05 (-4.55%)
11:02am
2020-04-16 $ 0.91 (1.68%)
7:00pm
2020-04-15 $ 0.91 (1.68%)
11:00am
2020-04-07 $ 0.71 (-3.4%)
3:00pm
2020-04-06 $ 0.735 (55.72%)
11:01am
2020-03-12 $ 0.55 (-17.74%)
11:00am
2020-02-21 $ 0.99 (-2.94%)
3:00pm
2020-02-20 $ 1.36 (3.82%)
7:00pm
2020-01-28 $ 1.16 (-3.33%)
11:02am
2020-01-27 $ 1.2 (-0.83%)
11:03am
2020-01-09 $ 1.1101 (14.42%)
7:00pm
2019-12-18 $ 0.8 (3.9%)
11:00am
2019-12-16 $ 0.78 (-2.5%)
11:00am
2019-10-05 $ 1 (%)
7:00pm
2019-09-25 $ 1.28 (1.59%)
7:00pm
2019-09-20 $ 1.28 (-22.42%)
11:00am
2019-08-21 $ 2.12 (0.95%)
11:00pm
2019-06-06 $ 2.46 (-13.38%)
3:00pm
2019-05-09 $ 3.37 (-11.32%)
7:01pm
2019-05-08 $ 3.8 (0.53%)
7:02pm
2019-03-27 $ 4.15 (-0.95%)
7:00pm
2019-03-19 $ 4.22 (5.5%)
11:02am
2019-03-13 $ 3.69 (0.54%)
7:02pm
2019-01-16 $ 3.6 (-10%)
11:07am
2018-12-22 $ 2.59 (-5.82%)
7:00pm
2018-11-19 $ 3 (3.45%)
11:00am
2018-11-07 $ 2.37 (%)
7:01pm
2018-11-06 $ 2.37 (%)
11:05am
2018-11-01 $ 2.18 (%)
11:02am
7:02pm
2018-09-25 $ 1.71 (%)
7:08am
2018-08-10 $ 2.02 (1.51%)
7:03pm
2018-08-03 $ 1.89 (-1.56%)
7:02pm
2018-06-01 $ 2.37 (-9.54%)
7:01pm
2018-05-09 $ 1.79 (-5.79%)
7:00pm
2018-05-08 $ 1.9 (1.6%)
7:03pm
2018-05-02 $ 1.68 (1.2%)
7:00pm
2018-04-09 $ 1.36 (0.74%)
7:00am
2013-10-13
3:18pm
2010-01-05 $ 491.94 (-0.26%)
12:39pm
Total 59
  • 1